Proliferation of estrogen-responsive mouse tumor cell line B-1F stimulated by Saiboku-to, but inhibited by Scutellaria baicalensis, a component of Saiboku-to

Oncology Reports

Volumn 22, Issue 2, 2009, Pages 257-264

  Murashima, Teruko ^a,b,c   Yamasaki, Megumi ^a,c   Nishizawa, Yoshio ^d,e   Katayama, Hiroshi ^a,c   Tanigaki, Yumiko ^a   Saeki, Yoshiko ^a   Shojiro, Kimura ^b   Nishizawa, Yasuko ^a,c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Apoptosis; Proliferation; Saiboku to; Scutellaria baicalensis

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ESSENTIAL OIL; FLAVONOID; IRIDOID; LEUKOTRIENE; SAIBOKU TO; SCUTELLARIA BAICALENSIS EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHINESE MEDICINE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; ENZYME INHIBITION; ESTROGEN BINDING; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LEYDIG CELL TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; ESTRADIOL; LEYDIG CELL TUMOR; MALE; MEDICINE, CHINESE TRADITIONAL; MEDICINE, KAMPO; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; SCUTELLARIA BAICALENSIS; TUMOR CELLS, CULTURED;

EID: 68349092520     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000432     Document Type: Article

References (21)

1. Hong SH, Avis I, Vos MD, Martinez A, Treston AM and Mulshine JL: Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res 59: 223-2228, 1999.
2. Shureiqi I and Lippman SM: Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61: 6307-6312, 2001.
3. Goto HG, Nishizawa Y, Katayama H, et al: Induction of apoptosis in an estrogen-responsive mouse Leydig tumor cell by leukotriene. Oncol Rep 17: 225-232, 2007.
4. Nishizawa Y, Yamamoto T, Terada N, Fushiki S, Amakata Y and Nishizawa Y: Effects of antiallergic drugs on the proliferation of estrogen-sensitive mouse Leydig cell line. Anticancer Res 16: 1241-1246, 1996.
5. Nishizawa Y, Nishizawa Y, Yamamoto T, et al: Progression of mouse transformed Leydig cells from estrogen-sensitive to estrogen-insensitive growth phenotype concomitant with loss of leukotriene D4 receptor. Int J Oncol 5: 1077-1084, 1994.
6. Sato B, Hirose T, Kasayama S, Takabayashi H, Koga M and Nishizawa Y: Transformed murine Leydig cells in serum-free culture: useful model for analysis of steroid hormone-induced cell growth and cell morphology (Review). Int J Oncol 1: 415-423, 1992.
7. Nishizawa Y, Yamamoto T, Taniguchi H and Sato B: Effects of estrogen and leukotrienes on anchorage-independent growth of transformed mouse Leydig cells under serum-free condition. Steroid Biochem (Life Sci Adv) 11: 23-28, 1992.
8. Nishii K, Nishizawa Y, Nishizawa Y, Matsumoto K and Sato B: Inhibition of murine transformed Leydig cell proliferation by leukotrienes in serum-free culture. Cancer Res 51: 5573-5578, 1991.
9. Nishizawa Y, Nishii K, Nishizawa Y, et al: Effects of estrogen on cell proliferation and leukotriene formation in tansformed mouse Leydig cells cultured under serum-free conditions. Cancer Res 50: 3866-3871, 1990.
10. Nishizawa Y, Nishii K, Kishimoto S, Matsumoto K and Sato B: Regulatory role of arachidonic acid-derived matabolites for proliferation of transformed murine Leydig cell in serum-free culture condition. Anticancer Res 10: 317-322, 1990.
11. Miyata T: Pharmacological basis of traditional medicines and health supplements as curatives. J Pharmacol Sci 103: 127-131, 2007.
12. Borchers AT, Hackman RM, Keen CL, Stern JS and Gershwin ME: Complementary medicine: a review of immunomodulatory effects of Chinese herbal medicines. Am J Clin Nutr 66: 1303-1312, 1997.
13. Villa E, Dugani A, Fantoni E, et al: Type of estrogen receptor determines response to antiestrogen therapy. Cancer Res 56: 3883-3885, 1996.
14. Nishizawa Y, Sato B, Nishii K, Kishimoto S and Matsumoto K: Effect of androgen on proliferation of estrogen-responsive transformed mouse Leydig cells in serum-free culture. Cancer Res 49: 1377-1382, 1989.
15. Zuo F, Zhou ZM and Liu ML: Determination of 14 chemical constituents in the traditional Chinese medicinal preparation Huangqin-Tang by high performance liquid chromatography. Biol Pharm Bull 24: 693-697, 2001.
16. Chan RY, Chen WF, Dong A, Guo D and Wong MS: Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 87: 3691-3695, 2002.
17. Han DH, Denison MS, Tachibana H and Yamada K: Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. Biosci Biotechnol Biochem 66: 1479-1487, 2002.
18. Bonham M, Posakony J, Coleman I, Montgomery B, Simon J and Nelson PS: Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 11: 3905-3914, 2005.
19. Zhang DY, Wu J, Ye F, et al: Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 63: 4037-4043, 2003.
20. Abe M and Yoshimoto T: Leukotriene-lipoxygenase pathway and drug discovery. Nippon Yakurigaku Zasshi 124: 415-425, 2004.
21. Liao HL and Hu MK: Synthesis and anticancer activities of 5,6,7-trimethylbaicalein derivatives. Chem Pharm Bull 52: 1162-1165, 2004.